IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

REBECA DEL RIO ARCE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1669771531
CMS profile
10973169
Location
KISSIMMEE, FL

General Payments · PY2021–2024

$2,269.93

  • Reported across 74 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,351.16

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family FL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,264.88 47
Education $86.28 4

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Bayer HealthCare Pharmaceuticals Inc. $341.34 13
CALLIDITAS THERAPEUTICS US INC. $276.97 14
Otsuka America Pharmaceutical, Inc. $171.66 7
Boehringer Ingelheim Pharmaceuticals, Inc. $158.85 4
ABBVIE INC. $126.90 2
Ardelyx, Inc. $110.63 4
OPKO Pharmaceuticals, LLC $86.28 4
Relypsa, Inc. $46.10 2
NOVARTIS PHARMACEUTICALS CORPORATION $32.43 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $358.37 8
PY2022 $116.73 1
PY2023 $443.67 14
PY2024 $1,351.16 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $110.78 10/21/2024 Food and Beverage Undisputed 01/23/2026 1107006547 CMS
ABBVIE INC. $16.12 10/22/2024 Food and Beverage Undisputed 01/23/2026 1107006549 CMS
Ardelyx, Inc. $26.93 01/16/2024 Food and Beverage Undisputed 01/23/2026 1146724086 CMS
Ardelyx, Inc. $23.79 03/14/2024 Food and Beverage Undisputed 01/23/2026 1146724088 CMS
Ardelyx, Inc. $30.77 09/30/2024 Food and Beverage Undisputed 01/23/2026 1146724090 CMS
Ardelyx, Inc. $29.14 12/08/2024 Food and Beverage Undisputed 01/23/2026 1146724092 CMS
Bayer Healthcare Pharmaceuticals Inc. $30.01 02/06/2024 Food and Beverage Undisputed 01/23/2026 1086349259 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.96 02/20/2024 Food and Beverage Undisputed 01/23/2026 1086299668 CMS
Bayer Healthcare Pharmaceuticals Inc. $33.67 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086277800 CMS
Bayer Healthcare Pharmaceuticals Inc. $32.75 05/13/2024 Food and Beverage Undisputed 01/23/2026 1086338967 CMS
Bayer Healthcare Pharmaceuticals Inc. $32.14 06/06/2024 Food and Beverage Undisputed 01/23/2026 1086344907 CMS
Bayer Healthcare Pharmaceuticals Inc. $30.19 07/02/2024 Food and Beverage Undisputed 01/23/2026 1086319476 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.28 07/10/2024 Food and Beverage Undisputed 01/23/2026 1086348795 CMS
Bayer Healthcare Pharmaceuticals Inc. $12.01 07/29/2024 Food and Beverage Undisputed 01/23/2026 1086099923 CMS
Bayer Healthcare Pharmaceuticals Inc. $25.69 08/22/2024 Food and Beverage Undisputed 01/23/2026 1086294954 CMS
Bayer Healthcare Pharmaceuticals Inc. $31.34 09/24/2024 Food and Beverage Undisputed 01/23/2026 1086358302 CMS
Bayer Healthcare Pharmaceuticals Inc. $29.02 10/24/2024 Food and Beverage Undisputed 01/23/2026 1086365241 CMS
Bayer Healthcare Pharmaceuticals Inc. $26.73 11/05/2024 Food and Beverage Undisputed 01/23/2026 1086353528 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.55 12/12/2024 Food and Beverage Undisputed 01/23/2026 1086335981 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.53 06/10/2024 Food and Beverage Undisputed 01/23/2026 1118104239 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $91.79 06/27/2024 Food and Beverage Undisputed 01/23/2026 1118104243 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.53 08/19/2024 Food and Beverage Undisputed 01/23/2026 1118104241 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.00 10/14/2024 Food and Beverage Undisputed 01/23/2026 1118104237 CMS
CALLIDITAS THERAPEUTICS US INC. $12.40 01/16/2024 Food and Beverage Undisputed 01/23/2026 1141508046 CMS
CALLIDITAS THERAPEUTICS US INC. $23.59 02/27/2024 Food and Beverage Undisputed 01/23/2026 1141510176 CMS
CALLIDITAS THERAPEUTICS US INC. $125.00 02/29/2024 Food and Beverage Undisputed 01/23/2026 1141510485 CMS
CALLIDITAS THERAPEUTICS US INC. $4.08 03/11/2024 Food and Beverage Undisputed 01/23/2026 1141511105 CMS
CALLIDITAS THERAPEUTICS US INC. $1.51 03/11/2024 Food and Beverage Undisputed 01/23/2026 1141511107 CMS
CALLIDITAS THERAPEUTICS US INC. $5.10 03/11/2024 Food and Beverage Undisputed 01/23/2026 1141511109 CMS
CALLIDITAS THERAPEUTICS US INC. $17.72 03/28/2024 Food and Beverage Undisputed 01/23/2026 1141512533 CMS
CALLIDITAS THERAPEUTICS US INC. $13.77 04/08/2024 Food and Beverage Undisputed 01/23/2026 1141512929 CMS
CALLIDITAS THERAPEUTICS US INC. $15.69 06/05/2024 Food and Beverage Undisputed 01/23/2026 1141516407 CMS
CALLIDITAS THERAPEUTICS US INC. $2.64 06/05/2024 Food and Beverage Undisputed 01/23/2026 1141516409 CMS
CALLIDITAS THERAPEUTICS US INC. $23.59 06/24/2024 Food and Beverage Undisputed 01/23/2026 1141517459 CMS
CALLIDITAS THERAPEUTICS US INC. $4.00 11/11/2024 Food and Beverage Undisputed 01/23/2026 1141526880 CMS
CALLIDITAS THERAPEUTICS US INC. $15.33 11/11/2024 Food and Beverage Undisputed 01/23/2026 1141526882 CMS
CALLIDITAS THERAPEUTICS US INC. $12.55 12/04/2024 Food and Beverage Undisputed 01/23/2026 1141528551 CMS
Novartis Pharmaceuticals Corporation $32.43 08/28/2024 Food and Beverage Undisputed 01/23/2026 1086923843 CMS
OPKO Pharmaceuticals, LLC $21.69 01/24/2024 Education Undisputed 01/23/2026 1112851880 CMS
OPKO Pharmaceuticals, LLC $24.62 05/07/2024 Education Undisputed 01/23/2026 1112851882 CMS
OPKO Pharmaceuticals, LLC $21.70 07/17/2024 Education Undisputed 01/23/2026 1112851884 CMS
OPKO Pharmaceuticals, LLC $18.27 11/14/2024 Education Undisputed 01/23/2026 1112851886 CMS
Otsuka America Pharmaceutical, Inc. $29.03 01/29/2024 Food and Beverage Undisputed 01/23/2026 1119057304 CMS
Otsuka America Pharmaceutical, Inc. $19.73 03/25/2024 Food and Beverage Undisputed 01/23/2026 1119057306 CMS
Otsuka America Pharmaceutical, Inc. $25.43 05/20/2024 Food and Beverage Undisputed 01/23/2026 1119057308 CMS
Otsuka America Pharmaceutical, Inc. $25.17 07/01/2024 Food and Beverage Undisputed 01/23/2026 1119057310 CMS
Otsuka America Pharmaceutical, Inc. $22.57 08/20/2024 Food and Beverage Undisputed 01/23/2026 1119057312 CMS
Otsuka America Pharmaceutical, Inc. $23.20 09/25/2024 Food and Beverage Undisputed 01/23/2026 1119057314 CMS
Otsuka America Pharmaceutical, Inc. $26.53 12/02/2024 Food and Beverage Undisputed 01/23/2026 1119057316 CMS
Vifor Pharma, Inc. $19.47 08/13/2024 Food and Beverage Undisputed 01/23/2026 1124057935 CMS
Vifor Pharma, Inc. $26.63 11/20/2024 Food and Beverage Undisputed 01/23/2026 1124059546 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.